Zacks Investment Research Upgrades Yield10 Bioscience (NASDAQ:YTEN) to Hold

Share on StockTwits

Yield10 Bioscience (NASDAQ:YTEN) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Sunday, Zacks.com reports.

According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global food security. The company is working on new approaches, to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism for better production. It operates primarily in Saskatoon, Saskatchewan, Canada. Yield10 Bioscience, Inc., formerly known as Metabolix, Inc., is based in Woburn, Massachusetts. “

A number of other research firms have also recently commented on YTEN. Maxim Group set a $9.00 price target on shares of Pitney Bowes and gave the stock a “buy” rating in a report on Friday, May 31st. National Securities restated a “buy” rating and issued a $10.00 price target on shares of Aqua Metals in a report on Friday, May 10th.

NASDAQ:YTEN opened at $0.95 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 4.49 and a quick ratio of 4.49. The firm has a market capitalization of $11.87 million, a PE ratio of -1.03 and a beta of 3.33. The business has a fifty day moving average of $0.88. Yield10 Bioscience has a 12 month low of $0.68 and a 12 month high of $1.77.

Yield10 Bioscience (NASDAQ:YTEN) last posted its quarterly earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $0.12 million during the quarter. Yield10 Bioscience had a negative net margin of 1,474.19% and a negative return on equity of 126.91%. On average, research analysts forecast that Yield10 Bioscience will post -0.58 EPS for the current year.

Yield10 Bioscience Company Profile

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.

Further Reading: What are the Benefits of Index Funds?

Get a free copy of the Zacks research report on Yield10 Bioscience (YTEN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Strategic Wealth Partners Ltd. Sells 294 Shares of FirstEnergy Corp.
Strategic Wealth Partners Ltd. Sells 294 Shares of FirstEnergy Corp.
Vanguard Real Estate ETF  Shares Sold by Strategic Wealth Partners Ltd.
Vanguard Real Estate ETF Shares Sold by Strategic Wealth Partners Ltd.
SPDR Portfolio Long Term Treasury ETF  Shares Sold by Strategic Wealth Partners Ltd.
SPDR Portfolio Long Term Treasury ETF Shares Sold by Strategic Wealth Partners Ltd.
Strategic Wealth Partners Ltd. Sells 2,592 Shares of ISHARES TR/CORE U S REIT ETF
Strategic Wealth Partners Ltd. Sells 2,592 Shares of ISHARES TR/CORE U S REIT ETF
Strategic Wealth Partners Ltd. Lowers Stock Holdings in Diageo plc
Strategic Wealth Partners Ltd. Lowers Stock Holdings in Diageo plc
Strategic Wealth Partners Ltd. Sells 11,768 Shares of iShares US Real Estate ETF
Strategic Wealth Partners Ltd. Sells 11,768 Shares of iShares US Real Estate ETF


© 2006-2019 Ticker Report